Company: CGCT
Filing Date: 2025-04-14
Form Type: S-1/A
Source: 0001104659-25-034635
Chunk: 168

Company: Cartesian Growth Corp III
Filing Date: 2025-04-14
Form: S-1/A
Chunk 168
---
 in money market funds meeting certain conditions under Rule 2a-7 under the Investment
Company Act which invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended
to be temporary and for the sole purpose of facilitating the intended business combination. To mitigate the risk that we might be deemed
to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the
trust account, we may, at any time (based on our management team’s ongoing assessment of all factors related to our potential status
under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust account and instead to hold the
funds in the trust account in cash or in an interest bearing demand deposit account at a bank. Due to the short-term nature of these
investments, we believe there will be no associated material exposure to interest rate risk.

Critical Accounting Estimates

We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statementsalso requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities,
costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe
to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. We have
not identified any critical accounting estimates.

<div align='center'>91</div>

Related Party Transactions

Pursuant to certain subscription agreements dated
October 29, 2024, on November 12, 2024, our initial shareholders paid an aggregate of $25,000, or approximately $0.004 per
share, to cover certain of our offering costs in exchange for an aggregate of 5,750,000 founder shares.

The number of founder shares outstanding was
determined based on the expectation that the total size of this offering would be a maximum of 23,000,000 units if the underwriters’
over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of the outstanding ordinary shares
after this offering. Up to 750,000 of the founder shares will be surrendered by our sponsor to us for no consideration depending on the
extent to which the underwriters’ over-allotment option is exercised. If we increase or decrease the size of this offering, we
will effect a share capitalization or a share repurchase or redemption or other